| Low fecal calprotectin correlates with histological remission and mucosal healing in ulcerative colitis and colonic Crohn's disease E Zittan, OB Kelly, R Kirsch, R Milgrom, J Burns, GC Nguyen, K Croitoru, ... Inflammatory bowel diseases 22 (3), 623-630, 2016 | 175 | 2016 |
| The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial H Yanai, A Levine, A Hirsch, RS Boneh, U Kopylov, HB Eran, NA Cohen, ... The Lancet Gastroenterology & Hepatology 7 (1), 49-59, 2022 | 118 | 2022 |
| Efficacy and safety of vedolizumab for induction of remission in inflammatory bowel disease—the Israeli real-world experience U Kopylov, Y Ron, I Avni-Biron, B Koslowsky, M Waterman, S Daher, ... Inflammatory bowel diseases 23 (3), 404-408, 2017 | 101 | 2017 |
| Higher adalimumab drug levels are associated with mucosal healing in patients with Crohn’s disease E Zittan, B Kabakchiev, R Milgrom, GC Nguyen, K Croitoru, AH Steinhart, ... Journal of Crohn's and Colitis 10 (5), 510-515, 2016 | 93 | 2016 |
| Modified two-stage ileal pouch-anal anastomosis results in lower rate of anastomotic leak compared with traditional two-stage surgery for ulcerative colitis E Zittan, N Wong-Chong, GW Ma, RS McLeod, MS Silverberg, Z Cohen Journal of Crohn's and Colitis 10 (7), 766-772, 2016 | 88 | 2016 |
| Lower serologic response to COVID-19 mRNA vaccine in patients with inflammatory bowel diseases treated with anti-TNFα H Edelman-Klapper, E Zittan, ABG Shitrit, KM Rabinowitz, I Goren, ... Gastroenterology 162 (2), 454-467, 2022 | 78 | 2022 |
| Use of faecal transplantation with a novel diet for mild to moderate active ulcerative colitis: the craft UC randomised controlled trial C Sarbagili Shabat, F Scaldaferri, E Zittan, A Hirsch, MC Mentella, ... Journal of Crohn's and Colitis 16 (3), 369-378, 2022 | 66 | 2022 |
| Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy U Kopylov, J Hanzel, C Liefferinckx, D De Marco, N Imperatore, N Plevris, ... Alimentary pharmacology & therapeutics 52 (1), 135-142, 2020 | 60 | 2020 |
| Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity E Zittan, OB Kelly, IM Gralnek, MS Silverberg, A Hillary Steinhart JGH Open, 2018 | 49 | 2018 |
| Development of the Harvey-Bradshaw Index-pro (HBI-PRO) score to assess endoscopic disease activity in Crohn’s disease E Zittan, B Kabakchiev, OB Kelly, R Milgrom, GC Nguyen, K Croitoru, ... Journal of Crohn's and Colitis 11 (5), 543-548, 2017 | 49 | 2017 |
| Preoperative anti–tumor necrosis factor therapy in patients with ulcerative colitis is not associated with an increased risk of infectious and noninfectious complications after … E Zittan, R Milgrom, GW Ma, N Wong-Chong, B O'Connor, RS McLeod, ... Inflammatory bowel diseases 22 (10), 2442-2447, 2016 | 49 | 2016 |
| High frequency of vitamin B12 deficiency in asymptomatic individuals homozygous to MTHFR C677T mutation is associated with endothelial dysfunction and … E Zittan, M Preis, I Asmir, A Cassel, N Lindenfeld, S Alroy, DA Halon, ... American Journal of Physiology-Heart and Circulatory Physiology 293 (1 …, 2007 | 46 | 2007 |
| Association of Vitamin B12 Deficiency with Homozygosity of the TT MTHFR C677T Genotype, Hyperhomocysteinemia, and Endothelial Cell Dysfunction. A Shiran, E Remer, I Asmer, B Karkabi, E Zittan, A Cassel, M Barak, ... The Israel Medical Association Journal: IMAJ 17 (5), 288-292, 2015 | 38 | 2015 |
| Colectomy rates did not decrease in paediatric-and adult-onset ulcerative colitis during the biologics era: a nationwide study from the epi-IIRN O Atia, E Orlanski-Meyer, R Lujan, N Ledderman, S Greenfeld, R Kariv, ... Journal of Crohn's and Colitis 16 (5), 796-803, 2022 | 30 | 2022 |
| Safety and effectiveness of ustekinumab for induction of remission in patients with Crohn’s disease: a multicenter Israeli study A Bar-Gil Shitrit, A Ben-Ya’acov, M Siterman, M Waterman, A Hirsh, ... United European Gastroenterology Journal 8 (4), 418-424, 2020 | 29 | 2020 |
| Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease—the Israeli real world experience U Kopylov, I Avni-Biron, Y Ron, B Koslowsky, M Waterman, S Daher, ... Digestive and Liver Disease 51 (1), 68-74, 2019 | 26 | 2019 |
| Disease activity in inflammatory bowel disease is associated with arterial vascular disease TR Card, E Zittan, GC Nguyen, MJ Grainge Inflammatory Bowel Diseases 27 (5), 629-638, 2021 | 25 | 2021 |
| Ileal pouch–anal anastomosis for ulcerative colitis: a Canadian institution’s experience E Zittan, GW Ma, N Wong-Chong, R Milgrom, RS McLeod, M Silverberg, ... International journal of colorectal disease 32, 281-285, 2017 | 18 | 2017 |
| I-CARE, a European prospective cohort study assessing safety and effectiveness of biologics in inflammatory bowel disease L Peyrin-Biroulet, JF Rahier, J Kirchgesner, V Abitbol, S Shaji, A Armuzzi, ... Clinical Gastroenterology and Hepatology 21 (3), 771-788. e10, 2023 | 17 | 2023 |
| Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism M Vardi, E Zittan, H Bitterman Cochrane Database of Systematic Reviews, 2009 | 17 | 2009 |
Mark S. SilverbergMount Sinai Hospital, University of TorontoVerified email at sinaihealth.ca
